China SXT Pharmaceuticals Inc (NASDAQ:SXTC) Sees Large Decline in Short Interest

China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the recipient of a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 134,000 shares, a decline of 84.3% from the June 30th total of 853,600 shares. Based on an average daily volume of 6,410,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 1.0% of the company’s stock are short sold.

NASDAQ:SXTC opened at $0.40 on Friday. The company’s 50 day moving average price is $0.50 and its 200-day moving average price is $0.62. China SXT Pharmaceuticals has a 52 week low of $0.34 and a 52 week high of $2.95.

Separately, ValuEngine upgraded shares of China SXT Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 1st.

An institutional investor recently raised its position in China SXT Pharmaceuticals stock. UBS Group AG lifted its holdings in China SXT Pharmaceuticals Inc (NASDAQ:SXTC) by 523.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,770 shares of the company’s stock after purchasing an additional 104,770 shares during the quarter. UBS Group AG owned 0.45% of China SXT Pharmaceuticals worth $66,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 10.20% of the stock is currently owned by institutional investors.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.

Featured Article: What is a put option?

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with's FREE daily email newsletter.